About
Technology
Issues
FAQ
Title
Abstract
Text
Figure Captions
Table Cells
Section Titles
Keywords
Subjects
Authors
From
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
To
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
All Types
Articles
Communications
Reviews
Discussions
Case Reports
Chapters
Books
News
Editorials
Order By
Order By Year ASC
Order By Year DESC
Order By Citations ASC
Order By Citations DESC
Go
Scientometrics
Impact Factor
Discipline Ranks
H-Index
G-Index
Articles
Citations
Article Citations
Citation Distribution
Search This Journal
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
exaly
›
Journals
›
Journal of Cardiovascular Pharmacology
›
Top Articles
Journal of Cardiovascular Pharmacology
Pharmacology
3.1
(top 5%)
Impact Factor
3.4
(top 5%)
extended IF
124
(top 2%)
H-Index
2K
authors
14.1K
papers
235.2K
citations
6.6K
citing journals
54.9K
citing authors
Most Cited Articles of Journal of Cardiovascular Pharmacology
Title
Year
Citations
Nitric oxide as a signaling molecule in the vascular system: an overview
1999
618
The importance of the hyperpolarizing mechanism increases as the vessel size decreases in endothelium-dependent relaxations in rat mesenteric circulation
1996
534
Impaired endothelium-dependent relaxation in rabbit pulmonary artery after subarachnoid hemorrhage
1996
518
The pharmacology of a beta 2-selective adrenoceptor antagonist (ICI 118,551)
1983
396
The Biochemical Pathways of Nitric Oxide Formation from Nitrovasodilators
1991
384
Effect of cilostazol, a cyclic AMP phosphodiesterase inhibitor, on the proliferation of rat aortic smooth muscle cells in culture
1992
376
The role of endothelium in cardiovascular homeostasis and diseases
1993
370
Energy metabolic phenotype of the cardiomyocyte during development, differentiation, and postnatal maturation
2010
363
Endogenous dimethylarginine as an inhibitor of nitric oxide synthesis
1992
347
Flow-Dependent, Endothelium-Mediated Dilation of Epicardial Coronary Arteries in Conscious Dogs
1984
347
Reduced urinary excretion of nitric oxide metabolites and increased plasma levels of asymmetric dimethylarginine in men with essential hypertension
1999
338
Rho kinase (ROCK) inhibitors
2007
299
On the Mechanism of NO Release from Sydnonimines
1989
291
Fibroblasts and myofibroblasts: what are we talking about?
2011
281
High-carbohydrate high-fat diet–induced metabolic syndrome and cardiovascular remodeling in rats
2011
275
The Role of Low-Dose Diuretics in Essential Hypertension
1993
253
Varying Extracellular [K+]
1993
248
Endothelial cells as mediators of vasodilation of arteries
1984
248
Cytokines regulate vascular functions related to stability of the atherosclerotic plaque
1995
245
Endothelin-1 and endothelin-3 release EDRF from isolated perfused arterial vessels of the rat and rabbit
1989
245
Rho-kinase as a novel therapeutic target in treatment of cardiovascular diseases
2002
236
COX-2 inhibitors and cardiovascular risk
2007
235
The effect of flavanol-rich cocoa on the fMRI response to a cognitive task in healthy young people
2006
230
Evidence that release of adenosine triphosphate from endothelial cells during increased shear stress is vesicular
2001
227
Fibrosis and cardiac arrhythmias
2011
219
previous
1985
1986
1987
How are inpact factors calculated?
The impact factor (IF) is calculated by counting citations from peer-reviewed journals only.
extended IF
also counts citations from books and conference papers. However, no patent, abstract, working papers, online documents, etc., are covered.
site/software ©
exaly
; All materials licenced under
CC by-SA
.